Joseph Ciaffoni
President and CEO at Collegium Pharmaceutical Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Collegium Pharmaceutical Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Indivior Pharmaceuticals Inc. May 13, 202699.9%
-
Indivior Pharmaceuticals Inc. May 8, 202599.9%
-
Collegium Pharmaceutical Inc. May 18, 202399.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Indivior Pharmaceuticals Inc. | Option exercise | +1,266,903 | — | — |
| Jun 22, 2026 | Indivior Pharmaceuticals Inc. | Shares withheld for tax | −612,549 | $38.32 | $23,472,878 |
| Feb 10, 2026 | Indivior Pharmaceuticals Inc. | Grant or award | +79,976 | — | — |
| Feb 12, 2024 | Collegium Pharmaceutical Inc. | Grant or award | +119,000 | — | — |
| Feb 12, 2024 | Collegium Pharmaceutical Inc. | Grant or award | +179,734 | — | — |
| Feb 12, 2024 | Collegium Pharmaceutical Inc. | Shares withheld for tax | −47,445 | $33.70 | $1,598,897 |
| Feb 12, 2024 | Collegium Pharmaceutical Inc. | Shares withheld for tax | −81,422 | $33.70 | $2,743,921 |
| Dec 21, 2023 | Collegium Pharmaceutical Inc. | Option exercise | +4,357 | $21.34 | $92,978 |
| Dec 21, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −4,357 | $30.38 | $132,366 |
| Dec 20, 2023 | Collegium Pharmaceutical Inc. | Option exercise | +26,454 | $21.34 | $564,528 |
| Dec 20, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −26,454 | $30.40 | $804,202 |
| Dec 19, 2023 | Collegium Pharmaceutical Inc. | Option exercise | +14,516 | $21.34 | $309,771 |
| Dec 19, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −14,516 | $30.03 | $435,915 |
| Dec 18, 2023 | Collegium Pharmaceutical Inc. | Option exercise | +27,798 | $21.34 | $593,209 |
| Dec 18, 2023 | Collegium Pharmaceutical Inc. | Open-market sale | −27,798 | $30.04 | $835,052 |
Questions about Joseph Ciaffoni
What boards is Joseph Ciaffoni on?
Joseph Ciaffoni sits on the boards of Collegium Pharmaceutical Inc. and Indivior Pharmaceuticals Inc.
Has Joseph Ciaffoni been a CEO?
Yes — Joseph Ciaffoni was CEO of Collegium Pharmaceutical Inc. (Until November 2024) and Indivior Pharmaceuticals Inc. (2026 – 2026).
How long has Joseph Ciaffoni served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.